1. Home
  2. IMNM vs GRNT Comparison

IMNM vs GRNT Comparison

Compare IMNM & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • GRNT
  • Stock Information
  • Founded
  • IMNM 2006
  • GRNT 2013
  • Country
  • IMNM United States
  • GRNT United States
  • Employees
  • IMNM N/A
  • GRNT N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • GRNT Blank Checks
  • Sector
  • IMNM Health Care
  • GRNT Finance
  • Exchange
  • IMNM Nasdaq
  • GRNT Nasdaq
  • Market Cap
  • IMNM 770.1M
  • GRNT 647.8M
  • IPO Year
  • IMNM 2020
  • GRNT N/A
  • Fundamental
  • Price
  • IMNM $7.46
  • GRNT $5.19
  • Analyst Decision
  • IMNM Strong Buy
  • GRNT Buy
  • Analyst Count
  • IMNM 5
  • GRNT 4
  • Target Price
  • IMNM $26.40
  • GRNT $7.70
  • AVG Volume (30 Days)
  • IMNM 1.1M
  • GRNT 403.3K
  • Earning Date
  • IMNM 05-16-2025
  • GRNT 05-08-2025
  • Dividend Yield
  • IMNM N/A
  • GRNT 8.49%
  • EPS Growth
  • IMNM N/A
  • GRNT N/A
  • EPS
  • IMNM N/A
  • GRNT 0.09
  • Revenue
  • IMNM $9,041,000.00
  • GRNT $392,965,000.00
  • Revenue This Year
  • IMNM N/A
  • GRNT $33.06
  • Revenue Next Year
  • IMNM $1,259.12
  • GRNT $10.17
  • P/E Ratio
  • IMNM N/A
  • GRNT $57.48
  • Revenue Growth
  • IMNM N/A
  • GRNT 5.65
  • 52 Week Low
  • IMNM $5.15
  • GRNT $4.52
  • 52 Week High
  • IMNM $19.07
  • GRNT $7.10
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.56
  • GRNT 52.52
  • Support Level
  • IMNM $7.15
  • GRNT $4.88
  • Resistance Level
  • IMNM $9.16
  • GRNT $5.11
  • Average True Range (ATR)
  • IMNM 0.51
  • GRNT 0.14
  • MACD
  • IMNM -0.08
  • GRNT 0.07
  • Stochastic Oscillator
  • IMNM 15.42
  • GRNT 92.44

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About GRNT Granite Ridge Resources Inc.

Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.

Share on Social Networks: